Prevalence of hand dysfunction in cerebral palsy following botulinum toxin therapy

被引:0
|
作者
Alahmar-Bianchin, M. [1 ]
Saraiva-Storti, H. C. [1 ]
Fornari-Chueire, R. [1 ]
Lucato, R. V., Jr. [1 ]
机构
[1] Fac Med, BR-15090040 Sao Jose do Rio Preto, SP, Brazil
关键词
botulinum toxin; cerebral palsy; functional independence; hand functioning; occupational therapy; proprioception;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim. To examine the level of dependence, the functional class, the most frequent type of compromise and the proprioception of the hand in spastic cerebral palsy following the application of botulinum toxin, as well as to determine the socio-demographic characteristics of the individuals involved. Patients and methods. We conducted a cross-sectional study of 21 spastic patients with extrinsic muscle involvement, of both sexes and a mean age of 15.4 +/- 5.6 years, who attended the neuro-rehabilitation outpatients department and were treated with botulinum toxin in the muscles responsible for the functional movements in the hand; they were evaluated after a mean period of 2.1 years. Patients were subjected to procedures such as a semi-structured interview, the FIM (Functional Independence Measurement) scale, Hausen's functional characterisation, Zancolli classification and a proprioception test. Results. There was a predominance of females (57% of patients) and of a basic level of schooling. On the FIM scale, 38% of the patients presented modified independence, without help; 23.8% belonged to Hansen grade 3 (grasping and holding an object steady with the help of the other hand). On the Zancolli classification, 54% belonged to type III (the fingers can only be extended if the fist is bent more than 70 degrees); perception of movement is absent (76.2%) and the sense of position of the movement is altered (54.2%). Conclusions. Findings confirmed the existence of a high rate of modified independence, grade 3 (Hausen), together with type III involvement (Zancolli) and alterations affecting proprioception. Data from the study show the importance of occupational therapy as part of the care received by patients with cerebral palsy following the administration of botulinum toxin type A.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 50 条
  • [41] Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy
    Manganotti, Paolo
    Zaina, Fabio
    Falso, Maurizio
    Milanese, Franco
    Fiaschi, Antonio
    JOURNAL OF REHABILITATION MEDICINE, 2007, 39 (02) : 115 - 120
  • [42] Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy
    Desloovere, Kaat
    Molenaers, Guy
    De Cat, Jos
    Pauwels, Petra
    Van Campenhout, Anja
    Ortibus, Els
    Fabry, Guy
    De Cock, Paul
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2007, 49 (01): : 56 - 61
  • [43] Cerebral palsy and botulinum toxin - reality check 2013
    Schroeder, A. S.
    Berweck, S.
    Heinen, F.
    NERVENHEILKUNDE, 2013, 32 (12) : 916 - 925
  • [44] Botulinum toxin for spasticity and athetosis in children with cerebral palsy
    Gooch, JL
    Sandell, TV
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (05): : 508 - 511
  • [45] 'Botulinum toxin A injection for children with spastic cerebral palsy'
    Wang YaJie
    Gao BaoQin
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2008, 50 (08): : 640 - 640
  • [46] Botulinum toxin type A in the treatment plan for cerebral palsy
    Strobl, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 : 30 - 35
  • [47] Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy"
    Langdon, Katherine
    Copeland, Lisa
    Edwards, Priya
    Rodwell, Kate
    McLennan, Kim
    Carroll, Theresa
    Bandaranayake, Sasaka
    Scheinberg, Adam
    Waugh, Mary-Clare
    Burnett, Heather
    Wimalasundera, Neil
    Hennel, Sabine
    Lim, Eewei
    O'Flaherty, Steve
    PEDIATRIC DRUGS, 2019, 21 (06) : 493 - 495
  • [48] The effect of botulinum toxin in the treatment of spasticity in cerebral palsy
    Watanabe, Y
    Bakheit, AMO
    McLellan, DL
    8TH WORLD CONGRESS OF THE INTERNATIONAL REHABILITATION MEDICINE ASSOCIATION (IRMA VIII), PTS 1-2, 1997, : 873 - 876
  • [49] Use of botulinum toxin type A in children with cerebral palsy
    Nolan, KW
    Cole, LL
    Tak, GSL
    PHYSICAL THERAPY, 2006, 86 (04): : 573 - 584
  • [50] Comment on: “Botulinum Toxin in the Management of Children with Cerebral Palsy”
    Katherine Langdon
    Lisa Copeland
    Priya Edwards
    Kate Rodwell
    Kim McLennan
    Theresa Carroll
    Sasaka Bandaranayake
    Adam Scheinberg
    Mary-Clare Waugh
    Heather Burnett
    Neil Wimalasundera
    Sabine Hennel
    Eewei Lim
    Steve O’Flaherty
    Pediatric Drugs, 2019, 21 : 493 - 495